has been cited by the following article(s):
[1]
|
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells
Journal of Medicinal Chemistry,
2017
DOI:10.1021/acs.jmedchem.7b00343
|
|
|
[2]
|
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
Future Medicinal Chemistry,
2017
DOI:10.4155/fmc-2017-0100
|
|
|
[3]
|
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells
Journal of Medicinal Chemistry,
2017
DOI:10.1021/acs.jmedchem.7b00343
|
|
|
[4]
|
Styryl-N-phenyl-N′-(2-chloroethyl)ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model
European Journal of Medicinal Chemistry,
2015
DOI:10.1016/j.ejmech.2015.05.034
|
|
|